BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4048165)

  • 21. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
    Park CG; Leenen FH
    J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats.
    Drolet G; Bouvier M; de Champlain J
    J Hypertens; 1989 Mar; 7(3):237-42. PubMed ID: 2708820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF; Oparil S
    Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats.
    Sasaki S; Nakata T; Kawasaki S; Hayashi J; Oguro M; Takeda K; Nakagawa M
    J Cardiovasc Pharmacol; 1990 May; 15(5):706-13. PubMed ID: 1692929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
    Chen YF; Jin HK; Gist R; Oparil S
    Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of the GABA receptor agonist muscimol in spontaneously hypertensive rats. Role of the sympathoadrenal axis.
    Unger T; Becker H; Dietz R; Ganten D; Lang RE; Rettig R; Schömig A; Schwab NA
    Circ Res; 1984 Jan; 54(1):30-7. PubMed ID: 6319038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of hypothalamic periventricular GABAergic nerves in the central pressor response to clonidine in freely-moving conscious rats.
    Hanafusa N; Okamoto K; Takatori S; Kawasaki H
    J Pharmacol Sci; 2012; 118(3):382-90. PubMed ID: 22450196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone.
    Allen AM
    Hypertension; 2002 Feb; 39(2):275-80. PubMed ID: 11847197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats.
    Bouvier M; de Champlain J
    J Auton Nerv Syst; 1986 Feb; 15(2):191-5. PubMed ID: 3958436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.
    Cabral AM; da Silva IF; Gardioli CR; Menegaz RG
    Auton Neurosci; 2000 Aug; 82(3):146-53. PubMed ID: 11023621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NaCl-induced hypertensive rat model of non-insulin-dependent diabetes: role of sympathetic modulation.
    Mozaffari MS; Patel C; Warren BK; Schaffer SW
    Am J Hypertens; 2000 May; 13(5 Pt 1):540-6. PubMed ID: 10826407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord.
    Hasséssian H; Prat A; De Champlain J; Couture R
    Eur J Pharmacol; 1991 Sep; 202(1):51-60. PubMed ID: 1723952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral GABAergic control of arterial blood pressure and heart rate in diabetic rats.
    Trimarchi GR; Squadrito F; Magri V; Ientile R; Costa G; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):307-21. PubMed ID: 3438569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic and pressor hyperresponsiveness to intracisternal injections of hypertonic NaCl in DOCA hypertensive rats.
    Takeda K; Sasaki S; Ashizawa H; Shikuma R; Takahashi H; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1981 Sep; 45(9):1126-9. PubMed ID: 7300022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic and medullary GABAA and GABAB-ergic systems differently regulate sympathetic and cardiovascular systems.
    Takenaka K; Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S48-50. PubMed ID: 9072440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of inhibiting brain reactive oxygen species on sympathetic nerve activity in DOCA-salt hypertensive rats].
    Zhang Q; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1632-6. PubMed ID: 25413063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.